This proposal outlines a study on the experience of laparoscopic cholecystectomy (gallbladder removal surgery) at St. Paul's Hospital Millennium Medical College in Addis Ababa, Ethiopia. The study will retrospectively review medical records from 2015-2020 to evaluate postoperative complications, conversion rates from laparoscopic to open surgery, and factors associated with complications. The objectives are to assess complication patterns, determine factors linked to complications, and calculate conversion rates and reasons. The proposal describes the background, literature review, methods, work plan, and budget for the study.
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
Percutaneous image-guided cryoablation of spinal metastases: A systematic reviewAhmad Ozair
Percutaneous cryoablation (PCA) is a minimally invasive technique that has been recently used to treat spinal metastases with a paucity of data currently available in the literature. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Prospective or retrospective studies concerning metastatic spinal neoplasms treated with current generation PCA systems and with available data on safety and clinical outcomes were included. In the 8 included studies (7 retrospective, 1 prospective), a total of 148 patients (females = 63%) underwent spinal PCA. Tumors were located in the cervical (3/109 [2.8%], thoracic (74/109 [68.8%], lumbar (37/109 [33.9%], and sacrococcygeal (17/109 [15.6%] regions. Overall, 187 metastatic spinal lesions were treated. Thermo-protective measures (e.g., carbo-/hydro-dissection, thermocouples) were used in 115/187 [61.5%] procedures. For metastatic spinal tumors, the pooled mean difference (MD) in pain scores from baseline on the 0–10 numeric rating scale was 5.03 (95% confidence interval [CI]: 4.24 to 5.82) at a 1-month follow-up and 4.61 (95% CI: 3.27 to 5.95) at the last reported follow-up (range 24–40 weeks in 3/4 studies). Local tumor control rates ranged widely from 60% to 100% at varying follow-ups. Grade I-II complications were reported in 9/148 [6.1%] patients and grade III-V complications were reported in 3/148 [2.0%]) patients. PCA, as a stand-alone or adjunct modality, may be a viable therapy in appropriately selected patients with painful spinal metastases who were traditionally managed with open surgery and/or radiation therapy.
A thoughtful presentation on participation in clinical trials from the Thomas Jefferson University team at the 2017 CURE OM Patient & Caregiver Symposium.
STARSurg, Tripartite Colorectal Conference, July 2014STARSurg
Tripartite is an international colorectal meeting of surgeons from across Europe, Australasia and the Americas.
Here we presented the colorectal-specific findings of STARSurg's first national collaborative cohort study, assesing the safety profile of NSAIDs in colorectal resection.
Percutaneous image-guided cryoablation of spinal metastases: A systematic reviewAhmad Ozair
Percutaneous cryoablation (PCA) is a minimally invasive technique that has been recently used to treat spinal metastases with a paucity of data currently available in the literature. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Prospective or retrospective studies concerning metastatic spinal neoplasms treated with current generation PCA systems and with available data on safety and clinical outcomes were included. In the 8 included studies (7 retrospective, 1 prospective), a total of 148 patients (females = 63%) underwent spinal PCA. Tumors were located in the cervical (3/109 [2.8%], thoracic (74/109 [68.8%], lumbar (37/109 [33.9%], and sacrococcygeal (17/109 [15.6%] regions. Overall, 187 metastatic spinal lesions were treated. Thermo-protective measures (e.g., carbo-/hydro-dissection, thermocouples) were used in 115/187 [61.5%] procedures. For metastatic spinal tumors, the pooled mean difference (MD) in pain scores from baseline on the 0–10 numeric rating scale was 5.03 (95% confidence interval [CI]: 4.24 to 5.82) at a 1-month follow-up and 4.61 (95% CI: 3.27 to 5.95) at the last reported follow-up (range 24–40 weeks in 3/4 studies). Local tumor control rates ranged widely from 60% to 100% at varying follow-ups. Grade I-II complications were reported in 9/148 [6.1%] patients and grade III-V complications were reported in 3/148 [2.0%]) patients. PCA, as a stand-alone or adjunct modality, may be a viable therapy in appropriately selected patients with painful spinal metastases who were traditionally managed with open surgery and/or radiation therapy.
A thoughtful presentation on participation in clinical trials from the Thomas Jefferson University team at the 2017 CURE OM Patient & Caregiver Symposium.
STARSurg, Tripartite Colorectal Conference, July 2014STARSurg
Tripartite is an international colorectal meeting of surgeons from across Europe, Australasia and the Americas.
Here we presented the colorectal-specific findings of STARSurg's first national collaborative cohort study, assesing the safety profile of NSAIDs in colorectal resection.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
The Flu-FIT Program : An Effective Colorectal Cancer Screening Intervention
Présentation de Michael B. Potter au colloque "Recherche interventionnelle contre le cancer : Réunir chercheurs, décideurs et acteurs de terrain » - 17 et 18 novembre 2014, BnF, Paris
Laparoscopic resections in colorectal malignancies by Dr Harsh Shah (www.gast...Dr Harsh Shah
This presentation explores the role of laparoscopy in comparison to open surgery with respect to oncological & other outcomes in colon & rectal cancer surgeries.
The final protocol (v5.3). Notable changes include:
1) Confirmation of audit standard (Page 6).
2) Refinement of inclusion and exclusion criteria (Page 7)
3) Confirmation of audit status (Appendix C)
4) Refinement of required data fields (Page 19) including definitions (Pages 20-25)
Enhanced Recovery After Surgery (ERAS®) is the Enhanced Recovery After Surgery (ERAS®) is the implementation of patient-focused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidencefocused, standardized, evidence-based, interdisciplinary perioperative guidelines.
Learn more about Enhanced Recovery Canada:
http://ow.ly/hR3j30jsnjR
Colorectal screening evidence & colonoscopy screening guidelines Health Evidence™
Health Evidence hosted a 90 minute webinar examining colorectal cancer screening: benefits and harms, effective screening methods, and screening guidelines.Click here for access to the audio recording for this webinar: https://www.youtube.com/watch?v=JqOV-KHCBq8
Donna Fitzpatrick-Lewis, MSW, Senior Research Coordinator at the McMaster Evidence Review and Synthesis Centre and Dr. Maria Bacchus, Associate Professor of Medicine, Faculty of Medicine University of Calgary, and member of the Canadian Task Force on Preventive Health Care led the session. Donna presented the findings of the Synthesis Centre’s latest review and Dr. Bacchus presented findings from the Task Force’s latest guidelines:
Fitzpatrick-Lewis, D., Usman, A., Warren, R., Kenny, M., Rice, M., Bayer, A., Ciliska, D., Sherifali, D., Raina, P. Screening for colorectal cancer. Ottawa: Canadian Task Force on Preventive Health Care; 2015. Available: http://canadiantaskforce.ca/files/crc-screeningfinal2.pdf
Bacchus, C. M., Dunfield, L., Gorber, S. C., Holmes, N. M., Birtwhistle, R., Dickinson, J. A., Lewin, G., Singh, H., Klarenbach, S., Mai, V., Tonelli, M. (2016). Recommendations on screening for colorectal cancer in primary care. Canadian Medical Association Journal, cmaj-151125.
Among men and women, colorectal cancer is the second and third most common cause of cancer related death, respectively. Colorectal cancer screening guidelines, developed by the Canadian Task Force on Preventive Health Care, are based on a systematic review synthesizing evidence on the benefits and harms of screening, and the characteristics of effective screening tests. The guidelines, developed from the review, outline screening recommendations for adults aged 50 and older who are asymptomatic and not at high risk for colorectal cancer. This webinar provided a high level overview of the systematic review that informed these recommendations, followed by an overview of the recent Canadian screening guidelines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Proposal presentation
1. St. Paul Hospital Millennium Medical College
Proposal on Experience of Laparoscopic Cholecystectomy in St. Paul’s
Hospital Millennium Medical College, Addis Ababa, Ethiopia
Investigator: Ashenafi Ermias(MD, GSR III)
January 2020
Addis Ababa, Ethiopia
2. Outline
• Introduction
• Literature review
• Statement of the problem
• Significance of the study
• Objectives
• Methods
• Work plan
• Cost of the project
• Acknowledgement
3. I. Introduction
• Gallstone disease is one of the most common conditions handled by a
general surgeons worldwide.
• Prevalence 10-15% in Europe and North America.
• Prevalence is even lower in Africa. (Brett M, 1976)
• No community based studies in Ethiopia;
• From hospital based study in Gondar, prevalence is about 5.2%. (Getachew A)
• Prevalence from hospital registry in SPHHMC was 8.9% ( Mahteme et al,2019)
• It is asymptomatic in about 80% of the patients.
• Symptomatic patients may present with biliary colic or with one of the
several complications.
4. • Laparoscopic cholecystectomy (LC) was introduced by Mühe of Germany in 1985
and since then it has been used in the management of gallstones. (Reynolds Jr W)
• Symptomatic patients are offered LC “the gold standard” treatment if the set up
allows
• Patient outcomes are superior in terms of surgical site infection, post operative
pain and hospital stay.
• But it has higher rate of biliary tree injury as compared to open cholecystectomy.
5. II. Literature review
• Outcomes of a surgical procedure can measured by morbidity and
mortality rates.
• Several studies have been conducted throughout the world regarding
the outcomes of LC.
• The incidence of bleeding has been reported to be up to 10%. It can
occur at any time starting from insertion of trocar to dissection or after
completion of the procedure due to slippage of clip.
6. • Mbatha et al reported 3 intraoperative bleeding out of 167 laparoscopic
cholecystectomies in a study they did in South Africa. All of the incidences were
handled laparoscopically. (Mbatha et al,2016)
• Older age did not affect the outcomes significantly as long as they have good
ASA functional status. But aged individuals tend to present with complications
and have higher ASA class. (Rafael S et al)
7. • Biliary tree injury remain the feared complication in LC
• In a study done by Engida et al in SPHMMC, they found significantly higher
number of biliary tree injury (2.3%) and higher for laparoscopic than open
technique. (2.3% vs 5.2%)
• Experience was the major factor responsible for the higher rate of bile duct injury.
(Engida A et al, 2014)
• Taki-Eldin reported 12 (of 492) patients had bile leak in a study done in Saudi
Arabia (7 due to CBD injury and 5 due slippage of cystic duct) (Taki-Eldin et
al,2018)
8. • Conversion to open surgery may be required in occasions where LC cannot be
completed because complication has occurred or as a preventive measure.
• In a study done in a private hospital in Addis Ababa, Bekele S et al reported conversion
rate of 2.9%. (Bekele et al, 2012)
• A study by Ballal M in England found a conversion rate of 5.2%; with higher conversion
rate for emergency cholecystectomy as compared to elective cholecystectomy. ( Ballal
M, 2009)
• Bowel injuries are less common during LC.
• In a US national survey, there were about 0.14% bowel injuries reported from 4,292
hospitals.
9. • Wound infections may complicate LC.
• Most publications have indicated lower SSI for LC than Open cholecytectomy
• Radunovic M et al reported infection of surgical wound in 7 out of 740 patients
(0.094%) in a study done in Montenegro. (Radunovic et al, 2016)
• One of the advantages of LC is the short post op stay.
• An average hospital stay of 1.1 day was reported by Clegg-Lamptey et al in
their paper evaluating LC in Korle Bu teaching Hospital Accra
Ghana.(Clegg-Lamptey et al, 2010)
10. • Operative time (duration of procedure) for laparoscopic
cholecystectomy have been reported ranging from 45-180 min.
• Rai P et al reported mean operating time of 79 min in their study.
(Rai P, 2016)
• Mean operating time in Myungsung Christian Medial center was
58.9min (Bekele et al, 2012)
• Pre-operative ultrasound can predict difficulty of LC.
• Of the 73 cases, 21 (28.76%) cases were predicted to be difficult,
17 (23.3%) were actually difficult, of which 13 (17.8%) were
converted to open procedure according to Lal P. (Lal P, 2012)
11. Statement of the Problem
• Laparoscopic cholecystectomy is associated with several
complications.
• This study looks into the following questions
• What is the pattern of biliary tree injury?
• What is the conversion rate and what factors influence conversion?
• What are the determinants of intra-op/post operative complications?
12. Significance of the study
• This study will help us judge the safety of laparoscopic
cholecystectomy in our set up
• It will be used as a source of data for future researches
13. III. Objectives
General objectives
To evaluate morbidity and mortality of laparoscopic cholecystectomy in
SPHMMC
Specific objectives
To assess the patterns of post-operative complications following
laparoscopic cholecystectomy
To determine factors associated with post-operative complications
To calculate the conversion rate and reasons for conversion
14. IV. METHODS
• Study setting: This study will be conducted in SPHMMC, Addis Ababa. The
hospital has been providing clinical service for over 50 years and teaching
undergraduate and postgraduate students in various clinical areas.
• Laparoscopic cholecystectomy was started in 2007 G.C and several patients have
undergone the procedure
• Study design: a cross-sectional study design will be utilized based on medical
records of patients who underwent laparoscopic cholecystectomies over the past
5years (January 2015 to December 2020 G.C.)
• Study population: the study population comprises of all patients who
undergone laparoscopic cholecystectomy
15. Sample size and sampling method
By using sample size calculation formula
n=
𝑍2
𝑝(1−𝑝)
𝑑2 n=sample size, p= proportion of attribute, d= margin of error
Proportion of attribute (prevalence) from a study done in a resource limited setup was
found to be 16.2% (p=0.162), the sample size of 209 patients will be included for this
study.
Form Operation theatre registration book, there were 210 patients operated over the
past 5 years and all patients who underwent laparoscopic cholecystectomy will be used
for this study
16. Data collection and analysis
• Medical records will be retrieved from central record room and data
will be collected by using a checklist.
• Data will be entered into SPSS version 26 and analyzed.
• Confidence interval of 95% with 5% margin of error and p<0.05 will
be used for statistical significance.
• Exclusion criteria: Medical records which lack/lost operation notes,
patients with CBD stone or jaundice will be excluded.
17. • Independent variables: age, sex, obesity, history of acute
cholecystitis, ASA class, previous surgery
• Dependent variables: conversion, intraoperative and post-operative
complications
• Ethical considerations: identity of the subjects will be kept
confidential.
• Ethical clearance will be obtained from college IRB.
18. Limitations of the study
• It is a retrospective study based on secondary data.
• Results cannot be generalized to indicate outcomes in other hospitals
since it is a single institution based study
19. V. WORK PLAN
November December January February March April May June July
Identification of research area
Formulate research questions and design
Literature review
Prepare research proposal
Proposal defense
Training
Pre-testing
Data collection
Analysis
Submission of initial draft
Submission of second draft
Thesis defense
Dissemination of results
20. VI. COST OF THE PROJECT
Personnel Quantity Cost/unit (ETB) Total cost (ETB)
Data collectors
Chart retrievers
4 202 12,120
4 100 8,800
Training 4 400 3200
Materials
A4 paper
Pen
Pencil
1 pac 200 200
2 pac 120 240
1 pac 40 40
Communication (air
time)
100 400
Total 25,000
21. Acknowledgement
• I am grateful to the guidance provided by my advisors Henok T. (MD,
Asst prof of Surgery), Birhane R. (MD, Asst prof of Surgery) and Tariku
S. (BSc, BA, MSc in Pharmaco-epidemiology)